Disagree
Home Keifei Pharma Keifei Pharma
Victorizafei Pen
Victorizafei Pen - Keifei Pharma

Victorizafei Pen - Keifei Pharma

Brand:
Category:
Substance:
Package:
1 pen
Price:
0
See options
Product Overview

Liraglutide offers a novel approach for managing hind-limb ischemia, a severe vascular complication of diabetes. In experimental models, liraglutide significantly improved blood flow reperfusion and enhanced capillary density in ischemic tissues. These effects were driven by its ability to activate endothelial nitric oxide synthase (eNOS) and ERK1/2 signaling pathways, improving endothelial cell migration and proliferation. In vitro studies with human umbilical vein endothelial cells demonstrated liraglutide's capacity to overcome hyperglycemia-related vascular dysfunction. Its GLP-1 receptor-mediated actions underline its potential for stimulating angiogenesis, providing a promising treatment for peripheral artery disease and ischemia.

References:

Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Victorizafei Pen by Keifei Pharma, consult with your doctor or healthcare professional.

Explore More Products
FAQ
Can Liraglutide improve angiogenesis in diabetes?
Yes, it enhances angiogenesis even under high-glucose conditions, overcoming hyperglycemia-induced endothelial dysfunction and aiding vascular repair in diabetic patients.
References:

Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.

What are the clinical implications of Liraglutide for ischemia?
Liraglutide offers a non-invasive alternative for treating chronic ischemic conditions like hind-limb ischemia, potentially reducing the need for surgeries and amputations.
References:

Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.

Is Liraglutide effective for non-diabetic patients with ischemia?
Studies show Liraglutide improves blood flow and capillary density in both diabetic and non-diabetic models, highlighting its broad therapeutic potential.
References:

Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.